Professor of Medicine, Brigham and Women's Hospital
Cardiology
Dr. Elliott M. Antman, MD
|
|
Give Review
Elliott Antman is an expert in the field of Cardiology. He went to medical school at Columbia University College of Physicians & Surgeons. Columbia University College of Physicians & Surgeons is a top medical college. Columbia University College of Physicians & Surgeons has a rank of 8 in research and a 52 in primary care He received 1 awards: "Super Doctor". Elliott M. Antman is also published. He has 98 publications published. The lastest publication: "PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.' He accepts Medicare.
Publications
- Improving Quality of Cardiac Care: A Global Mandate.
- PON1 Q192R genetic variant and response to clopidogrel and prasugrel: pharmacokinetics, pharmacodynamics, and a meta-analysis of clinical outcomes.
- Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
- Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
- Edoxaban vs. warfarin in vitamin K antagonist experienced and naive patients with Atrial fibrillationâ
- Fibrinolysis Use Among Patients Requiring Interhospital Transfer for ST-Segment Elevation Myocardial Infarction Care: A Report From the US National Cardiovascular Data...
- Population and personalized medicine in the modern era.
- Diltiazem Treatment for Pre-Clinical Hypertrophic Cardiomyopathy Sarcomere Mutation Carriers: A Pilot Randomized Trial to Modify Disease Expression.
- New oral anticoagulants in patients with Atrial fibrillation - Authors'reply.
- Cerebrovascular Events in 21 105 Patients With Atrial Fibrillation Randomized to Edoxaban Versus Warfarin: Effective Anticoagulation With Factor Xa Next Generation in ...
- Patterns of Long-term Thienopyridine Therapy and Outcomes in Patients With Acute Coronary Syndrome Treated With Coronary Stenting: Observations From the TIMI-38 Corona...
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with Atrial fibrillation: a meta-analysis of randomised trials.
- Left Atrial structure and function in Atrial fibrillation: ENGAGE AF-TIMI 48.
- Concomitant Administration of Clopidogrel With Statins or Calcium Channel Blockers: Insights From the TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcom...
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation.
- Discharge Aspirin Dose and Clinical Outcomes in Patients with Acute Coronary Syndromes treated with Prasugrel vs. Clopidogrel: An Analysis from the TRITON-TIMI 38 Study.
- Full Prescription Coverage Versus Usual Prescription Coverage After Coronary Artery Bypass Graft Surgery: Analysis From the Post-Myocardial Infarction Free Rx Event an...
- Circadian Variation of Stent Thrombosis and the Effect of More Robust Platelet Inhibition: A Post Hoc Analysis of the TRITON-TIMI 38 Trial.
- Bypassing the Emergency Department to Improve the Process of Care for ST-Elevation Myocardial Infarction: Necessary but Not Sufficient.
- Dynamic TIMI Risk Score for STEMI.
- Transforming clinical trials in cardiovascular Disease: mission critical for health and economic well-being.
- Acute Hyperkalemia Detected by Alert from Implantable Cardioverter-Defibrillator.
- ACC/AHA/ESC/WHF Universal Definition of Myocardial Infarction Classification System and the Risk of Cardiovascular Death: Observations from the TRITON-TIMI 38 Trial.
- Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies.
- Use of Emergency Medical Service Transport Among Patients With ST-Segment-Elevation Myocardial Infarction: Findings From the National Cardiovascular Data Registry Acut...
- Predictors of Bleeding and Time Dependence of Association of Bleeding With Mortality: Insights From the Trial to Assess Improvement in Therapeutic Outcomes by Optimizi...
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: ...
- 2011 ACCF/AHA Focused Update of the Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction (Updating the 2007 Guideline)...
- 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction A...
- Evidence and education.
- Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis.
- Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with Atrial fibrillation: design and rationale for the Effective aNticoaGulatio...
- Prasugrel.
- Mortality in the TRITON trial: update from the FDA prasugrel action package.
- Bundle branch block in ST-elevation Myocardial infarction: evidence for action.
- Extent of ST-segment resolution after fibrinolysis adds improved risk stratification to clinical risk score for ST-segment elevation Myocardial infarction.
- 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation Myocardial infarction (updating the 2004 guideline and 2007 focused update) a...
- Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation Acute coronary syndrome (from the international trial SY...
- The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with Acute coronary syndromes undergoing percutaneous intervention:...
- Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38.
- Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural Myocardial infarction in the Trial to Assess Improvement in Therap...
- Cytochrome P450 genetic polymorphisms and the response to prasugrel: relationship to pharmacokinetic, pharmacodynamic, and clinical outcomes.
- Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation Myocardial infarction.
- Tools for guiding clinical practice from the american Heart association and the american college of cardiology: what are they and how should clinicians use them?
- Baseline hemoglobin concentration and creatinine clearance composite laboratory index improves risk stratification in ST-elevation Myocardial infarction.
- Cytochrome p-450 polymorphisms and response to clopidogrel.
- Evaluation of high-sensitivity assays for cardiac troponin.
- Time is muscle: translation into practice.
- The specialty of emergency medicine: needed now more than ever before.
- Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeuti...
- Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with Acute coronary syndromes from the TRITON-TIMI 38 trial.
- Biomarker release after percutaneous Coronary intervention: a message from the heart.
- Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-Myocardial infarction secondary preventive therapies.
- Early and late benefits of prasugrel in patients with Acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improve...
- Cost-effectiveness of providing full drug coverage to increase medication adherence in post-Myocardial infarction Medicare beneficiaries.
- Effect of thrombocytopenia on outcomes following treatment with either enoxaparin or unfractionated heparin in patients presenting with Acute coronary syndromes.
- Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation Acute coronary syndromes: results from the SYNERGY trial.
- ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology/A...
- Diabetes and mortality following Acute coronary syndromes.
- Development of systems of care for ST-elevation Myocardial infarction patients: executive summary.
- Development of systems of care for ST-elevation Myocardial infarction patients: the patient and public perspective.
- Global outcomes of ST-elevation myocardial infarction: comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysi...
- The impact of renal dysfunction on outcomes in the ExTRACT-TIMI 25 trial.
- Outcomes and optimal antithrombotic therapy in women undergoing fibrinolysis for ST-elevation Myocardial infarction.
- Hemodynamic significance of periprocedural myocardial injury assessed with N-terminal pro-B-type natriuretic peptide after percutaneous Coronary intervention in patien...
- Bleeding complications in patients with Acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timel...
- Should patients receive secondary prevention medications for free after a Myocardial infarction? An economic analysis.
- The cardiovascular Disease continuum validated: clinical evidence of improved patient outcomes: part I: Pathophysiology and clinical trial evidence (risk factors throu...
- The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes: part II: Clinical trial evidence (Acute coronary syndromes through rena...
- Cardiology patient pages. Modern treatment for Heart attacks: opening blocked arteries quickly.
- Hospital delays in reperfusion for ST-elevation Myocardial infarction: implications when selecting a reperfusion strategy.
- Clinical guidelines and practice: in search of the truth.
- Combination of quantitative ST deviation and troponin elevation provides independent prognostic and therapeutic information in unstable Angina and non-ST-elevation myo...
- Oral anticoagulation for Atrial fibrillation after ST-elevation myocardial infarction: new evidence to guide clinical practice.
- Cyclooxygenase inhibition and cardiovascular risk.
- Correlation between the TIMI risk score and high-risk angiographic findings in non-ST-elevation Acute coronary syndromes: observations from the Platelet Receptor Inhib...
- Abciximab as adjunctive therapy to reperfusion in Acute ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
- Dual antiplatelet therapy for Coronary stenting: a clear path for a research agenda.
- Association of smoking with improved Myocardial perfusion and the angiographic characterization of Myocardial tissue perfusion after fibrinolytic therapy for ST-segmen...
- Angiography and revascularization in patients with heart failure following fibrinolytic therapy for ST-elevation Acute myocardial infarction.
- Geographic variability in patient characteristics, treatment and outcome in an International Trial of Magnesium in Acute myocardial infarction.
- Task force 1: The ACCF and AHA codes of conduct in human subjects research.
- Usefulness of tirofiban among patients treated without percutaneous Coronary intervention (TIMI high risk patients in PRISM-PLUS).
- Primary percutaneous coronary intervention versus fibrinolytic therapy in Acute myocardial infarction: does the choice of fibrinolytic agent impact on the importance o...
- Performance of the thrombolysis in Myocardial infarction risk index in the National Registry of Myocardial Infarction-3 and -4: a simple index that predicts mortality ...
- ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction; A report of the American College of Cardiology/American Heart Association Ta...
- Angiographic perfusion score: an angiographic variable that integrates both epicardial and tissue level perfusion before and after facilitated percutaneous Coronary in...
- B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation Myocardial infarction: an ENTIRE-TIMI-23 substudy.
- Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation Acute corona...
- Validated risk score predicts the development of congestive heart failure after presentation with unstable Angina or non-ST-elevation myocardial infarction: results fr...
- Clopidogrel resistance: a new chapter in a fast-moving story.
- Pharmacoinvasive therapy: the future of treatment for ST-elevation Myocardial infarction.
- Combined assessment of thrombolysis in Myocardial infarction flow grade, Myocardial perfusion grade, and ST-segment resolution to evaluate epicardial and Myocardial re...
- Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in Acute myocardial infarction.
- Invasive therapy along with glycoprotein IIb/IIIa inhibitors and intracoronary stents improves survival in non-ST-segment elevation Acute coronary syndromes: a meta-an...
- Time delay to treatment and mortality in primary angioplasty for Acute myocardial infarction: every minute of delay counts.
- Implications of upstream glycoprotein IIb/IIIa inhibition and coronary artery stenting in the invasive management of unstable Angina/non-ST-elevation myocardial infarc...
Schools
Columbia University College Of Physicians and Surgeons
Colum Presby Med Center
Peter Bent Brigham Hospital
Procedures Preformed
- Ablation for Treatment of Cardiac Arrhythmias
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- Aortic Valve Disease
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Super Doctor
Education
-
Brigham and Women's Hospital -
New York Presbyterian Hospital - Columbia Campus -
Columbia University College of Physicians & Surgeons
Hospital
-
Brigham and Women's Hospital
Drug Facts
| NPI NUMBER | 1598721748 | |
| NPPES Provider LastName | ANTMAN | |
| NPPES Provider FirstName | ELLIOTT | |
| NPPES Provider ZIPCode | 02115 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 230.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1598721748 |
| Last Name Of The Provider | ANTMAN |
| First Name Of The Provider | ELLIOTT |
| View All |
Similar Doctors
|
|
Dr. Byungdoo A. Yi, MD |
|
|
Dr. Thomas J. Wang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rajeev Malhotra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sekar Kathiresan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brett J. Carroll, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjay Maniar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane S. Bae, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hicham Skali Lami, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katarina H. Nelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryann Williamson, MD |
|
|
Dr. Ian Del Conde Pozzi, MD |
|
Dr. Venkatesan D. Vidi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Chang-Seng Liang, MD |
|
|
Dr. Gary J. Balady, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Santosh C. Varkey, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ivan Luptak Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald A. Weiner, MD
This Doctor is OpenDoctor Recommended.
|